Samung investing in Grail - exclusive rights in South Korea

The latest news about Grail centers on a major strategic collaboration with Samsung! That's amazing news.

Grail has announced a major strategic partnership with Samsung, which includes a $110 million investment and exclusive rights for Samsung to commercialize Grail’s Galleri cancer test in Asia, starting with South Korea. This collaboration is expected to expand Grail’s reach and strengthen its financial position while Samsung increases its involvement in cancer diagnostics!

https://www.prnewswire.com/news-releases/samsung-and-grail-announce-strategic-collaboration-to-bring-grails-galleri-multi-cancer-early-detection-test-to-asia-302586298.html